太龙药业取消发行2025年度第一期科技创新债券

Core Viewpoint - The announcement indicates that Henan Tailong Pharmaceutical Co., Ltd. has canceled the issuance of its first phase of technology innovation bonds for 2025 due to recent market volatility [1] Group 1: Bond Issuance Details - The initial issuance amount for the bonds was set at 0 billion, with a maximum issuance limit of 4 billion [1] - The planned issuance dates were September 18 and September 19, 2025 [1] Group 2: Future Plans - Henan Tailong Pharmaceutical intends to reissue the bonds at a later date after consulting with the lead underwriter [1] - The company will comply with the relevant regulations for the subsequent issuance, repayment, and information disclosure of the technology innovation bonds [1] Group 3: Market Performance - As of the market close, Henan Tailong Pharmaceutical's stock price was reported at 6.43 yuan per share [1]